Castle Biosciences Inc
CSTL· Nasdaq
CSTLCastle Biosciences Inc
Filed Sep 3, 2019 · 10-Q · 65 days after period end · 0001447362-19-000011
| Metric | Q2 2019 | Q2 2018 |
|---|---|---|
| Revenue | $10.74M | $3.98M |
| Net Income | -$1.27M | -$3.16M |
| EPS Diluted | -$1.05 | -$2.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Castle Biosciences Inc · CIK 1447362 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Sep 3, 2019 · 65 d after period end
